Trial intelligence / Profile preview

Ezetimibe on Glucose Metabolism in T2DM

NCT01611883Phase 4Completed

Sponsor
Organon & Co.
Start
Jul 2012
Primary completion
Jan 2014
Modality
Small Molecules
01

Overview

A Phase 4 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started Jul 2012; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT01611883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01611883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call